ARALEZ PHARMACEUTICALS INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
ARALEZ PHARMACEUTICALS INC. reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction of $80.76 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesDeductions · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2018-03-31 was $80.76M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 3 month |
|---|---|
| 2018-03-31 | $80.76M 10-Q · filed 2018-05-08 |